Divis Laboratories Declines 2.52% Amid Mixed Signals and Rising Derivatives Activity
2026-11-21 17:05:06Key Events This Week 16 Nov: Intraday low amid price pressure (Rs.11,134.85) 17 Nov: Marginal recovery with slight price gain 18 Nov: Price dips amid broader market weakness 19 Nov: Strong rebound with highest volume of the week 20 Nov: Significant open interest surge in derivatives despite slight price decline Week OpenRs.11,489.65 ...
Read More
Divis Laboratories Sees Significant Open Interest Surge Amidst Mixed Market Signals
2026-11-20 15:00:23Divis Laboratories Ltd, a large-cap stalwart in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 13.03% increase in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a marginal dip in the stock price, the surge in OI alongside rising delivery volumes suggests a complex interplay of directional bets and market sentiment.
Read More
Divis Laboratories Sees Significant Open Interest Surge Amidst Stable Price Action
2026-11-20 14:00:15Divis Laboratories Ltd, a large-cap leader in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 12.56% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning despite a marginal dip in its share price. This development reflects growing interest in the stock’s future prospects amid a stable trading range and improving fundamentals.
Read More
Divis Laboratories Sees Significant Open Interest Surge Amid Mixed Price Action
2026-11-20 13:00:15Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a slight dip in the stock price, the underlying volume and OI data suggest evolving directional bets that merit close attention from market participants.
Read More
Divis Laboratories Ltd Hits Intraday Low Amid Price Pressure on 16 Nov 2026
2026-11-16 11:37:22Shares of Divis Laboratories Ltd declined sharply today, touching an intraday low of Rs 11,134.85, marking a 3.09% drop as the stock underperformed its sector and broader market indices amid subdued intraday momentum and immediate selling pressure.
Read MoreDivis Laboratories Gains 11.50%: 6 Key Factors Driving the Week’s Momentum
2026-11-14 17:02:33Key Events This Week 09 Nov: New 52-week and all-time high at Rs.11,786.1 09 Nov: Surge in call and put option activity ahead of 23 Nov expiry 11 Nov: Intraday low amid price pressure and heavy put option volumes 13 Nov: Week closes at Rs.11,489.65 (+11.50%) Week OpenRs.10,305.00 Week CloseRs.1...
Read More
Divis Laboratories Ltd is Rated Buy
2026-11-14 10:10:04Divis Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 07 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 November 2026, providing investors with an up-to-date view of its performance and prospects.
Read More
Divis Laboratories Ltd Hits Intraday Low Amid Price Pressure on 11 Nov 2026
2026-11-11 12:36:32Divis Laboratories Ltd experienced a notable intraday decline on 11 Nov 2026, touching a low of Rs 11,194, reflecting a 3.25% drop from its previous close. This downturn marks a reversal after a sustained 12-day rally, with the stock underperforming its sector and broader market indices amid shifting market dynamics and investor sentiment.
Read More
Rs 10,000 Puts — 13.5% Below Current Price — Draw 3,336 Contracts on Divis Laboratories Ltd
2026-11-09 10:00:07Rs 10,000 put options on Divis Laboratories Ltd attracted 3,336 contracts on 9 Nov 2026, despite the stock trading robustly at Rs 11,549. The significant distance between strike and spot price suggests the put activity is more nuanced than a straightforward bearish bet.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
13-Nov-2026 | Source : BSEsubmission of transcript of Q2Fy27 earnings call held on November 07 2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
09-Nov-2026 | Source : BSEAs Enclosed
Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2026
07-Nov-2026 | Source : BSEAs per enclosed.
Corporate Actions
No Upcoming Board Meetings
Divis Laboratories Ltd has declared 1500% dividend, ex-date: 24 Jul 26
Divis Laboratories Ltd has announced 2:10 stock split, ex-date: 03 Aug 07
Divis Laboratories Ltd has announced 1:1 bonus issue, ex-date: 23 Sep 15
No Rights history available